In the fast‑moving world of medical devices, clarity is essential. Whether you’re preparing for a merger or acquisition, evaluating internal performance, or ensuring compliance before scaling, AKRA TEAM provides a rigorous, independent assessment of your regulatory, quality, and clinical landscape.
Our Due Diligence service gives you a realistic, evidence‑based snapshot of your current situation – highlighting strengths, weaknesses, risks, and concrete solutions.
Because due diligence must assess not only regulatory compliance, but the real health, scalability, and risk profile of a business.
AKRA TEAM specializes exclusively in regulatory, clinical, and quality frameworks for medical devices and diagnostics, and brings a pragmatic business lens to every audit and assessment. We go far beyond generic management consultancies by evaluating processes, teams, and systems in the context of commercial realities, growth plans, and transaction risk.
We provide:
Unbiased, investor‑grade evaluations performed by experienced regulatory strategists with a strong understanding of how MedTech businesses operate
Actionable, decision‑ready findings, not generic observations; clearly distinguishing critical issues from acceptable, manageable risk
Clear risk–benefit insights that support high‑stakes business decisions such as acquisitions, investments, partnerships, and market expansion
Industry‑aligned recommendations grounded in MDR, IVDR, FDA, MDSAP, ISO 13485, and global best practices, with a focus on operational impact and remediation feasibility
A comprehensive, independent review of your regulatory positioning to determine compliance and its impact on market access, risk, and business objectives.
Typical activities include:
Outcome:A clear, decision‑ready view of compliance status, key risks, and realistic effort required to achieve or sustain conformity and market access.
An evaluation of how effectively teams and processes support both compliance obligations and business performance across the organization.
Key aspects assessed include:
Benefit from a clearer system with fewer barriers to effective operations and continuous improvement over time.
Outcome: A clear view of operational readiness to support regulatory demands, upcoming milestones, and sustainable growth — with targeted, feasible improvement opportunities.
When large investments or transactions are at stake, independent due diligence becomes critical. We support both buyers and sellers in evaluating the real regulatory, clinical, and quality status of a company or device portfolio.
We help investors, strategic buyers, and industry players understand:
We prepare companies for a smooth, confident transaction by:
Outcome: You will get a transparent, realistic evaluation that reduces the risk of investment, increases the transaction value, and minimizes surprises after a deal is made.
Every Due Diligence engagement ends with: